Q2 2015 Holdings
Filed 2015-08-14 | 69 holdings | $308.6K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2015-09-09) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Allergan PLCA | SHS | G0177J108 | $13.7K | 45,000 | 4.4% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $12.2K | 575,000 | 3.9% |
| Biogen Inc(BIIB)A | COM | 09062X103 | $12.1K | 30,000 | 3.9% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $11.1K | 235,000 | 3.6% |
| Alnylam Pharmaceuticals Inc(ALNY)A | COM | 02043Q107 | $10.8K | 90,000 | 3.5% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $10.6K | 425,000 | 3.4% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $9.7K | 20,000 | 3.1% |
| Endo Intl PLCA | SHS | G30401106 | $9.6K | 120,000 | 3.1% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $9.2K | 75,000 | 3.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $9.0K | 50,000 | 2.9% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $7.7K | 170,000 | 2.5% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $7.4K | 60,000 | 2.4% |
| Horizon Pharma PLC | SHS | G4617B105 | $6.9K | 200,000 | 2.3% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $6.8K | 750,000 | 2.2% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $6.2K | 400,000 | 2.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $6.1K | 75,000 | 2.0% |
| Cepheid | COM | 15670R107 | $6.1K | 100,000 | 2.0% |
| Cigna Corporation | COM | 125509109 | $6.1K | 37,500 | 2.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $6.0K | 250,000 | 1.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $5.9K | 122,500 | 1.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $5.3K | 375,000 | 1.7% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $5.3K | 100,000 | 1.7% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.2K | 65,000 | 1.7% |
| Aetna Inc New | COM | 00817Y108 | $5.1K | 40,000 | 1.7% |
| Anacor Pharmaceuticals Inc | COM | 032420101 | $5.0K | 65,000 | 1.6% |
| Uniqure NV(QURE) | SHS | N90064101 | $5.0K | 185,000 | 1.6% |
| Endochoice Hldgs Inc | COM | 29272U103 | $4.9K | 300,000 | 1.6% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $4.8K | 100,000 | 1.6% |
| Cellectis S A(CLLS)A | SPONSORED ADS | 15117K103 | $4.5K | 125,000 | 1.5% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $4.4K | 350,000 | 1.4% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $4.4K | 150,000 | 1.4% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $4.3K | 262,696 | 1.4% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $4.2K | 350,000 | 1.4% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $4.2K | 57,500 | 1.4% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $4.2K | 289,200 | 1.3% |
| Wright MED Group Inc | COM | 98235T107 | $3.9K | 150,000 | 1.3% |
| Alcobra LTD | SHS | M2239P109 | $3.9K | 600,000 | 1.3% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $3.9K | 75,000 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM NEW | 867328601 | $3.8K | 1,250,000 | 1.2% |
| Genocea Biosciences Inc | COM | 372427104 | $3.7K | 270,000 | 1.2% |
| Assembly Biosciences Inc | COM | 045396108 | $3.4K | 175,000 | 1.1% |
| Anthem Inc(ELV) | COM | 036752103 | $3.3K | 20,000 | 1.1% |
| Rockwell MED IncCall | COM | 774374102 | $3.2K | 200,000 | 1.0% |
| Kempharm Inc | COM | 488445107 | $3.2K | 175,000 | 1.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $3.2K | 350,000 | 1.0% |
| Therapeuticsmd Inc | COM | 88338N107 | $3.1K | 400,000 | 1.0% |
| Axovant Sciences LTD | COM | G0750W104 | $2.8K | 135,000 | 0.9% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $2.6K | 250,000 | 0.8% |
| Avalanche Biotechnologies inCall | COM | 05337G107 | $2.4K | 150,000 | 0.8% |
| Biodelivery Sciences Intl in(BDSIUSD) | COM | 09060J106 | $2.4K | 300,000 | 0.8% |